Corcept Endocrinology President Sean Maduck disposes of 30,955 Corcept shares worth $3.88 million
CORT•Maduck exercises options and sells shares
Corcept Therapeutics President, Corcept Endocrinology Sean Maduck exercised stock options for 30,955 common shares at USD 11.35 on Aug. 25.
Maduck sold 30,955 common shares the same day for about USD 125.47 to USD 126.06 per share.
Directly owned common shares fell to 9,755 following the transactions.
Maduck reported 169,045 stock options outstanding following the exercise.
